These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [The value of magnetic resonance imaging in the surveillance of fibromatosis. A study of 10 cases]. Vanel D; Ubaldino V; Coffre C; Genin J; Contesso G; Sarrazin D J Radiol; 1989 Jan; 70(1):33-6. PubMed ID: 2715965 [TBL] [Abstract][Full Text] [Related]
3. CT-guided radiofrequency ablation in the palliative treatment of recurrent advanced head and neck malignancies. Brook AL; Gold MM; Miller TS; Gold T; Owen RP; Sanchez LS; Farinhas JM; Shifteh K; Bello JA J Vasc Interv Radiol; 2008 May; 19(5):725-35. PubMed ID: 18440462 [TBL] [Abstract][Full Text] [Related]
4. Combined percutaneous radiofrequency ablation and ethanol injection of renal tumours: midterm results. Fotiadis NI; Sabharwal T; Morales JP; Hodgson DJ; O'Brien TS; Adam A Eur Urol; 2007 Sep; 52(3):777-84. PubMed ID: 17400364 [TBL] [Abstract][Full Text] [Related]
5. Protecting the ureter during radiofrequency ablation of renal cell cancer: a pilot study of retrograde pyeloperfusion with cooled dextrose 5% in water. Cantwell CP; Wah TM; Gervais DA; Eisner BH; Arellano R; Uppot RN; Samir AE; Irving HC; McGovern F; Mueller PR J Vasc Interv Radiol; 2008 Jul; 19(7):1034-40. PubMed ID: 18589317 [TBL] [Abstract][Full Text] [Related]
6. Repeat radiofrequency ablation for local progression of lung tumors: does it have a role in local tumor control? Hiraki T; Mimura H; Gobara H; Sano Y; Fujiwara H; Date H; Kanazawa S J Vasc Interv Radiol; 2008 May; 19(5):706-11. PubMed ID: 18440459 [TBL] [Abstract][Full Text] [Related]
9. Radiofrequency ablation in combination with embolization in metachronous recurrent renal cancer in solitary kidney after contralateral tumor nephrectomy. Gebauer B; Werk M; Lopez-Hänninen E; Felix R; Althaus P Cardiovasc Intervent Radiol; 2007; 30(4):644-9. PubMed ID: 17436034 [TBL] [Abstract][Full Text] [Related]
12. [Treatment of postoperative recurrence of hepatocellular carcinoma with radiofrequency ablation comparing with repeated surgical resection]. Ren ZG; Gan YH; Fan J; Chen Y; Wu ZQ; Qin LX; Ge NL; Zhou J; Xia JL; Wang YH; Ye QH; Wang L; Ye SL Zhonghua Wai Ke Za Zhi; 2008 Nov; 46(21):1614-6. PubMed ID: 19094752 [TBL] [Abstract][Full Text] [Related]
13. Percutaneous radiofrequency ablation with transarterial embolization is useful for treatment of stage 1 renal cell carcinoma with surgical risk: results at 2-year mean follow up. Arima K; Yamakado K; Kinbara H; Nakatsuka A; Takeda K; Sugimura Y Int J Urol; 2007 Jul; 14(7):585-90; discussion 590. PubMed ID: 17645597 [TBL] [Abstract][Full Text] [Related]
14. Percutaneous thermal ablation of medium and large hepatocellular carcinoma: long-term outcome and prognostic factors. Yin XY; Xie XY; Lu MD; Xu HX; Xu ZF; Kuang M; Liu GJ; Liang JY; Lau WY Cancer; 2009 May; 115(9):1914-23. PubMed ID: 19241423 [TBL] [Abstract][Full Text] [Related]
15. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome. Zytoon AA; Ishii H; Murakami K; El-Kholy MR; Furuse J; El-Dorry A; El-Malah A Jpn J Clin Oncol; 2007 Sep; 37(9):658-72. PubMed ID: 17766723 [TBL] [Abstract][Full Text] [Related]
16. Percutaneous radiofrequency thermal ablation of renal cell carcinoma: is it possible a day-hospital treatment? Carrafiello G; Laganà D; Ianniello A; Mangini M; Fontana F; Cotta E; Concollato L; Marconi A; Recaldini C; Dionigi G; Rovera F; Boni L; Cuffari S; Fugazzola C Int J Surg; 2008; 6 Suppl 1():S31-5. PubMed ID: 19200792 [TBL] [Abstract][Full Text] [Related]
17. Radiofrequency ablation for recurrent pelvic cancer. Lefevre JH; Parc Y; Lewin M; Bennis M; Tiret E; Parc R Colorectal Dis; 2008 Oct; 10(8):781-4. PubMed ID: 18028468 [TBL] [Abstract][Full Text] [Related]